ViiV/Janssen Forge Two-Drug Future For HIV With SWORD Filings

 
• By Alexandra Shimmings

The battle of the HIV giants ViiV Healthcare and Gilead Sciences continues with the first filing for a two-drug regimen for use against HIV infection in the US and EU.

boat anchored in a bay, luxury yacht
Why rock the boat? Will doctors go for a two-drug regimen? • Source: Shutterstock

More from New Products

More from Scrip